Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 2 |
2013 | 1 |
2014 | 1 |
2018 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer.
J Pers Med. 2021 May 16;11(5):420. doi: 10.3390/jpm11050420.
J Pers Med. 2021.
PMID: 34065723
Free PMC article.
miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer.
Campayo M, Navarro A, Benítez JC, Santasusagna S, Ferrer C, Monzó M, Cirera L.
Campayo M, et al. Among authors: cirera l.
PLoS One. 2018 Nov 2;13(11):e0206542. doi: 10.1371/journal.pone.0206542. eCollection 2018.
PLoS One. 2018.
PMID: 30388154
Free PMC article.
Item in Clipboard
Leptomeningeal Carcinomatosis in a Patient With Clinical Stage III Lung Adenocarcinoma and Sudden Neurological Impairment.
Benítez JC, Bastús R, Luizaga L, Cirera L, Campayo M.
Benítez JC, et al. Among authors: cirera l.
Arch Bronconeumol (Engl Ed). 2018 Jun;54(6):344-345. doi: 10.1016/j.arbres.2018.01.019. Epub 2018 Feb 26.
Arch Bronconeumol (Engl Ed). 2018.
PMID: 29496285
English, Spanish.
No abstract available.
Item in Clipboard
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study).
Fernandez-Plana J, Pericay C, Quintero G, Alonso V, Salud A, Mendez M, Salgado M, Saigi E, Cirera L; ACROSS Study Group.
Fernandez-Plana J, et al. Among authors: cirera l.
BMC Cancer. 2014 Nov 22;14:865. doi: 10.1186/1471-2407-14-865.
BMC Cancer. 2014.
PMID: 25417182
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer.
Muñoz A, Pericay C, García-Girón C, Alonso V, Dueñas R, Cirera L, Rivera F, Falcó E, Bustos IA, Salud A.
Muñoz A, et al. Among authors: cirera l.
Oncol Res. 2013;21(4):181-91. doi: 10.3727/096504014X13887748696743.
Oncol Res. 2013.
PMID: 24762224
Clinical Trial.
Item in Clipboard
Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register.
Puente J, López-Tarruella S, Ruiz A, Lluch A, Pastor M, Alba E, de la Haba J, Ramos M, Cirera L, Antón A, Llombart A, Plazaola A, Fernández-Aramburo A, Sastre J, Díaz-Rubio E, Martin M.
Puente J, et al. Among authors: cirera l.
Breast Cancer Res Treat. 2010 Jul;122(2):591-600. doi: 10.1007/s10549-009-0687-4. Epub 2010 Jan 10.
Breast Cancer Res Treat. 2010.
PMID: 20063196
Item in Clipboard
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer.
Roca JM, Alonso V, Pericay C, Escudero P, Salud A, Losa F, López LJ, Guasch I, Méndez M, Quintero-Aldana G, Grande C, Vicente P, Arrivi A, Martin C, Moreno I, García P, Antón I, Constenla M, Yubero A, Cirera L; ACROSS Cooperative Group.
Roca JM, et al. Among authors: cirera l.
Chemotherapy. 2010;56(2):142-6. doi: 10.1159/000313527. Epub 2010 Apr 21.
Chemotherapy. 2010.
PMID: 20407241
Clinical Trial.
Item in Clipboard
Cite
Cite